Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tepper

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|April 9, 1999
Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosisA D Tepper, E de Vries, W J van Blitterswijk, et al.
Journal of Clinical Pharmacology|July 1, 1983
Effects of amrinone on atrioventricular conduction in the intact canine heartA Nusrat, D Tepper, J Hertzberg, et al.
Cardiology Clinics|February 1, 1993
Identification of patients with high risk of arrhythmic mortality. Role of ambulatory monitoring, signal-averaged ECG, and heart rate variabilityJ A Gomes, S L Winters, J Ip, et al.
Journal of Clinical Pharmacology|October 1, 1984
The efficacy of cibenzoline in preventing PES induction of ventricular tachycardia in the dogG Keren, D Tepper, B Butler, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 10, 2006
New physiological functions for drug-transporting P-glycoproteins?P Borst, W J van Blitterswijk, J Borst, et al.
Cardiovascular Research|December 1, 1985
Size and shape of enzymatically isolated ventricular myocytes from rats and cardiomyopathic hamstersA L Sorenson, D Tepper, E H Sonnenblick, et al.
Journal of the American College of Cardiology|October 1, 1984
Studies on the possible mechanisms of lidoflazine arrhythmogenicityG Keren, D Tepper, B Butler, et al.
The Journal of Biological Chemistry|September 26, 1997
CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibitionA D Tepper, J G Cock, E de Vries, et al.
The Journal of Biological Chemistry|April 29, 1998
CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinaseJ G Cock, A D Tepper, E de Vries, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1991
Determinants of pace-terminable ventricular tachycardia: implications for implantable antitachycardia devicesJ H Ip, S L Winters, P Schweitzer, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|April 9, 1999
Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosisA D Tepper, E de Vries, W J van Blitterswijk, et al.
Journal of Clinical Pharmacology|July 1, 1983
Effects of amrinone on atrioventricular conduction in the intact canine heartA Nusrat, D Tepper, J Hertzberg, et al.
Cardiology Clinics|February 1, 1993
Identification of patients with high risk of arrhythmic mortality. Role of ambulatory monitoring, signal-averaged ECG, and heart rate variabilityJ A Gomes, S L Winters, J Ip, et al.
Journal of Clinical Pharmacology|October 1, 1984
The efficacy of cibenzoline in preventing PES induction of ventricular tachycardia in the dogG Keren, D Tepper, B Butler, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 10, 2006
New physiological functions for drug-transporting P-glycoproteins?P Borst, W J van Blitterswijk, J Borst, et al.
Cardiovascular Research|December 1, 1985
Size and shape of enzymatically isolated ventricular myocytes from rats and cardiomyopathic hamstersA L Sorenson, D Tepper, E H Sonnenblick, et al.
Journal of the American College of Cardiology|October 1, 1984
Studies on the possible mechanisms of lidoflazine arrhythmogenicityG Keren, D Tepper, B Butler, et al.
The Journal of Biological Chemistry|September 26, 1997
CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibitionA D Tepper, J G Cock, E de Vries, et al.
The Journal of Biological Chemistry|April 29, 1998
CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinaseJ G Cock, A D Tepper, E de Vries, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1991
Determinants of pace-terminable ventricular tachycardia: implications for implantable antitachycardia devicesJ H Ip, S L Winters, P Schweitzer, et al.
Pageof 6